HOME >> MEDICINE >> NEWS
Hormone may offer hope for treating some behavioral disorders

SAN FRANCISCO Do you ever wonder how the brain determines its response to emotional stimuli? Researchers have now shown a correlation between secretin, a hormone found in gut and brain tissue, and how the brain responds to affective stimuli. Details and implications of this study will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 May 1, 2004.

Studies using magnetic resonance imaging (MRI) methods have found that individuals with a range of behavioral disorders including schizophrenia, depression, bipolar illness and autism have abnormal amygdala activation in response to facial emotions and other social stimuli. The amygdala, a part of the limbic brain, has emerged as one of the most critical areas influencing how we respond emotionally. It has also been shown to play an important role in emotional learning and in the attribution of emotional significance to stimuli. These MRI findings point to amygdala dysfunction as a potential neurobiological factor in the development of these disorders.

Recent evidence suggests that secretin may modulate the functional response of the amygdala. "We wanted to test the hypothesis that administration of secretin alters amygdala responsiveness to affective stimuli in healthy adult males," notes study author Deborah Yurgelun-Todd, PhD, of McLean Hospital and Harvard Medical School, Belmont, Mass.

The ability to detect and measure the effects of secretin in the brain is important in three ways. It is consistent with animal studies that report altered amygdala response after secretin administration. It also indicates that administration of this agent can be monitored using neuroimaging methods, therefore providing an important method for studying both brain and behavioral effects of secretin. Finally, and perhaps most promising given that abnormalities of amygdala function have been implicated in a variety of behavioral and psychiatric disorders, studi
'"/>

Contact: Kathy Stone
kstone@aan.com
651-695-2763
American Academy of Neurology
27-Apr-2004


Page: 1 2

Related medicine news :

1. Hormone therapy increases risk of urinary incontinence
2. Hormone therapy controversy raises drug safety issues
3. Endocrine Society and Hormone Foundation call for increased research
4. Hormone therapy may still offer important health benefits to postmenopausal women
5. Hormone found to protect bones
6. Hormone released by bone marrow cells may hasten recovery from brain injury
7. Hormones increase side effects, complicate treatment decision for prostate cancer patients
8. Hormones and drugs that control blood pressure also control malaria infection
9. Hormone replacement therapy reviewing the evidence
10. Hormone prompts adult stem cells to differentiate into islet cells
11. Hormone therapy study stopped due to increased breast cancer risk, lack of overall benefit

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® ... largest population and the greatest number of sufferers of blindness. “We think that ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... manufacturing network, the Company will be ceasing operations and ... Huntsville, Alabama . The closure of the facilities ... to 18 months. The Huntsville ... products and these restructuring actions are intended to better ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., ... medical testing, strengthening and rehabilitation equipment, today announced the ... Program. MedX is considered the gold standard for the ... in specialized medical strengthening equipment. ... lease with the physician or practice who prescribe the ...
Breaking Medicine Technology:
Cached News: